Trade Idea of The Day - Apollo Hospitals Enterprise Ltd Target Rs.200 - Religare Broking Ltd
NiveshIQ
Apollo Hospitals Enterprise Ltd.
NiveshIQ has detected 5 active signals on APOLLOHOSP. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Enterprise Limited operates a diversified healthcare portfolio across India, delivering primary, secondary and tertiary care through its hospitals, specialty centres and diagnostic arm. The core revenue drivers are inpatient services (cardiac, oncology, neurology, orthopedics), outpatient clinics and diagnostic tests, which together accounted for ₹26,430 Cr in FY2025. Recent developments include securing creditor approval for a composite restructuring scheme and a sharp increase in open interest signalling bullish market sentiment. Apollo’s competitive edge lies in its integrated digital health platform, Medvarsity e‑learning, and a robust network of 70+ hospitals, positioning it ahead of regional rivals in service breadth and technology adoption. The company’s growth outl
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹19,059 Cr +14.73% | ₹21,794 Cr +14.35% | ₹25,228 Cr +15.76% |
| EBITDA Margin | 12.54% | 13.87% | 14.94% |
| Net Profit | ₹898.60 Cr +9.71% | ₹1,446 Cr +60.91% | ₹1,942 Cr +34.29% |
| EPS | ₹62.50 | ₹100.56 | ₹135.04 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Apollo Hospitals Enterprise (NSE:APOLLOHOSP) nine months ended December 2025 financial results and operating trends
Apollo Hospitals secures creditor nod for composite scheme
Strategic Outlook
- Q1FY27 results: revenue ₹7, 044 Cr, PAT ₹581 Cr, EPS ₹40.39, EBITDA margin 15.5%. Growth context: revenue YoY +20.6%, PAT YoY +34.2%, revenue QoQ +6.6%, PAT QoQ +9.7%. Street verdict: beat, revenue surprise +2.2%, PAT surprise +34.0%.
Test volumes, test mix, B2B/reference-lab traction, pricing discipline, and operating leverage remain the key forward dr...
FY26 (last completed FY): revenue ₹25, 228 Cr, PAT ₹1, 942 Cr, EBITDA margin 14.9%, EPS ₹135.04. Year-on-year: revenue Y...
More Healthcare stocks
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Apollo Hospitals Enterprise Ltd.?
NiveshIQ detects active intelligence signals for Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Apollo Hospitals Enterprise Ltd.?
Apollo Hospitals Enterprise Ltd. operates in the Healthcare sector with a market capitalisation of ₹11,620,675.7L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.